TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 3 | 1 | 4 | 7 | -2 | 5 | 9 | 30 | -14 | 6 |
| P | %wins | 50 | 50 | 50 | 25 | 50 | 25 | 42 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
4/22/15 14:45 | 4/20/15 | CDTX | Cidara Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Kjellson Nina S | CA | D | P.d | 3,200 | 16.00 | 17 | 200 | 17 | 1,357 | I | -1 | -1 | -2 | 9 | -2 | -1 | -6 | ||||||||
11/12/13 17:27 | 11/8/13 | OCRX | Ocera Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Kjellson Nina S | CA | D | P.d | 0 | 0.00 | 0 | 422 | 51 | 1,248 | I | -82 | -85 | 6 | 0 | -12 | -11 | -4 | -4 | 0 | 3 | 56 | 84 | 0 | -27 | |
7/17/13 16:12 | 7/15/13 | OCRX | Ocera Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Kjellson Nina S | CA | D | P.d | 2,600 | 6.03 | 0 | 431 | 109 | 826 | I | -88 | -88 | -18 | 21 | -10 | 4 | 2 | 6 | 33 | 5 | -28 | -9 | 132 | -44 | |
8/10/10 13:50 | 8/6/10 | TSRX | Trius Therapeutics Inc | DE | Health | Drug | Pharmaceutical Preparations | Kjellson Nina S | CA | DT | P.d | 6,137 | 5.00 | 3 | 1,227 | 53 | 3,549 | I | -9 | -5 | -12 | -19 | -36 | -12 | 21 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |